Advanced search
Publication Cover
Infection and Drug Resistance Volume 12, 2019 - Issue
Submit an article Journal homepage
127
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China

Ming Luo1 Central Laboratory, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Kun Li1 Central Laboratory, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Huizheng Zhang1 Central Laboratory, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Xiaofeng Yan2 Department of Tuberculosis, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Jing Gu3 Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan430071, People’s Republic of China
,
Zhen Zhang4 Department of Pharmacy, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Yu Chen5 Department of Medical Records, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Jungang Li1 Central Laboratory, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
,
Jing Wang1 Central Laboratory, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of China
&
Yaokai Chen1 Central Laboratory, Chongqing Public Health Medical Center, Chongqing400036, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2269-2275 | Published online: 24 Jul 2019

References

  • Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa110878922670902
  • World Health Organization (WHO). Global Tuberculosis Report 2018. Geneva: WHO; 2018.
  • Lehmann J. Para-aminosalicylic acid in the treatment of tuberculosis. Lancet. 1946;247(6384):15–16. doi:10.1016/S0140-6736(46)91185-3
  • Lehmann J. Twenty years afterward historical notes on the discovery of the antituberculosis effect of para-aminosalicylic acid (PAS) and the first clinical trials. Am Rev Respir Dis. 1964;90:953–956. doi:10.1164/arrd.1964.90.6.95314233801
  • Dookie N, Rambaran S, Padayatchi N, Mahomed S, Naidoo K. Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J Antimicrob Chemother. 2018;73(5):1138–1151. doi:10.1093/jac/dkx50629360989
  • Chakraborty S, Gruber T, Barry CE 3rd, Boshoff HI, Rhee KY. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science. 2013;339(6115):88–91. doi:10.1126/science.122898023118010
  • Zheng J, Rubin EJ, Bifani P, et al. para-aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem. 2013;288(32):23447–23456. doi:10.1074/jbc.M113.47579823779105
  • Rengarajan J, Sassetti CM, Naroditskaya V, Sloutsky A, Bloom BR, Rubin EJ. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol. 2004;53(1):275–282. doi:10.1111/j.1365-2958.2004.04120.x15225321
  • Zhao F, Wang XD, Erber LN, et al. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2014;58(3):1479–1487. doi:10.1128/AAC.01775-1324366731
  • Fivian-Hughes AS, Houghton J, Davis EO. Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid. Microbiology. 2012;158(Pt 2):308–318. doi:10.1099/mic.0.053983-022034487
  • Zhang D, An J, Wang J, et al. Molecular typing and drug susceptibility of Mycobacterium tuberculosis isolates from Chongqing municipality, China. Infect Genet Evol. 2013;13:310–316. doi:10.1016/j.meegid.2012.10.00823183314
  • Pang Y, Dong H, Tan Y, et al. Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Sci Rep. 2016;6:25330. doi:10.1038/srep2533027149911
  • World Health Organization. WHO Guidelines Approved by the Guidelines Review Committee. Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs. Geneva: World Health Organization; 2008.
  • Larkin MA, Blackshields G, Brown NP, et al. Clustal W and clustal X version 2.0. Bioinformatics. 2007;23(21):2947–2948. doi:10.1093/bioinformatics/btm40417846036
  • Pang Y, Zhou Y, Zhao B, et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One. 2012;7(3):e32976. doi:10.1371/journal.pone.003297622412962
  • Tan Y, Su B, Zheng H, Song Y, Wang Y, Pang Y. Molecular characterization of prothionamide-resistant Mycobacterium tuberculosis isolates in Southern China. Front Microbiol. 2017;8:2358. doi:10.3389/fmicb.2017.0235829250048
  • Pang Y, Zhu D, Zheng H, et al. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. BMC Infect Dis. 2017;17(1):711. doi:10.1186/s12879-017-2761-629110640
  • Zhang X, Liu L, Zhang Y, Dai G, Huang H, Jin Q. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012. Antimicrob Agents Chemother. 2015;59(2):1320–1324. doi:10.1128/AAC.03695-1425421465
  • Cheng VW, Leung KS, Kwok JS, et al. Phylogenetic and structural significance of dihydrofolate synthase (folc) mutations in drug-resistant Mycobacterium tuberculosis. Microb Drug Resist. 2016;22(7):545–551. doi:10.1089/mdr.2015.019327082669
  • Mathieu M, Debousker G, Vincent S, Viviani F, Bamas-Jacques N, Mikol V. Escherichia coli FolC structure reveals an unexpected dihydrofolate binding site providing an attractive target for anti-microbial therapy. J Biol Chem. 2005;280(19):18916–18922. doi:10.1074/jbc.M41379920015705579
  • Mathys V, Wintjens R, Lefevre P, et al. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2009;53(5):2100–2109. doi:10.1128/AAC.01197-0819237648

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.